Picture of Amplia Therapeutics logo

ATX — Amplia Therapeutics News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Amplia Therapeutics Says Dose Escalation Approved In Accent Clinical Trial Of Amp945

Jan 11 (Reuters) - Amplia Therapeutics Ltd  ATX.AX :
    * DOSE ESCALATION APPROVED IN ACCENT CLINICAL TRIAL OF
AMP945

Source text for Eikon:  ID:nASXJVJMH 
Further company coverage:  ATX.AX 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Amplia Therapeutics

See all news